Hyperlipoproteinemia enhances susceptibility to acute disseminated Candida albicans infection in low-density-lipoprotein-receptor-deficient mice

Infection and Immunity

Volumn 65, Issue 7, 1997, Pages 2663-2667

  Netea, Mimai G ^a   Demacker, Pierre N M ^a   De Bont, Natasja ^a   Boerman, Otto C ^a   Stalenhoef, Anton F H ^a   Van der Meer, Jos W M ^a   Kullberg, Bart Jan ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL GROWTH; CANDIDA ALBICANS; CANDIDIASIS; GENETIC SUSCEPTIBILITY; GROWTH REGULATION; HYPERLIPOPROTEINEMIA; INFECTION; INFLAMMATORY CELL; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTECTION;

EID: 0030954099     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.7.2663-2667.1997     Document Type: Article

References (32)

1. Beck-Sagué, C. M., W. R. Jarvis, and the National Nosocomial Infections Surveillance System. l993. Secular trends in the epidemiology of nosocomial fungal infections in the United Suites. 1980-1990. J. Infect. Dis. 167:1247-1251.
2. Beutler, B., I. W. Milsark, and A. C. Cerami. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:809-871.
3. Burnie, J. P. 1995. Early diagnosis of systemic fungal infection. Curr. Opin. Infect. Dis. 8:258-260.
4. Cannon, J. G., R. G. Tomkins, J. A. Gelfand, H. R. Michie, G. G. Stanford, J. W. M. Van der Meer, S. Endres, G. Lonnemann, J. Corsetto, B. Chemow, D. W. Wilmore, S. M. Wolff, J. F. Burke, and C. A. Dinarello. 1990. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J. Infect. Dis. 161:79-84.
5. D'Angio, K., R. A. Quercia, N. K. Treiber, J. C. Mclaughlin, and J. Klimek. 1987. The growth of microorganisms in total parenteral nutrition admixtures. J. Parenter. Enteral. Nutr. 11:394-397.
6. Djeu, J. Y., D. K. Blanchard, D. Halkias, and H. Friedman. 1986. Growth inhibition of Candida albians by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor. J. Immunol. 137:2980-2984.
7. Esfahani, M., R. D. Bigler, J. L. Alfieri, S. Lund-Katz, J. D. Baum, and L. Scerbo. 1993. Cholesterol regulates the cell surface expression of glycophospholipid-anchored CD14 antigen on human monocytes. Biochim. Biophys. Acta 1149:217-223.
8. Fraker, P. J., and J. C. Speck. 1978. Protein and cell membrane iodination with a sparingly soluble chloramide 1,3,4,6-tetrachloro-3α,6α-diphenylglucoril. Biochem. Biophys. Res. Commun. 80:849-857.
9. Gilbert, M., S. C. Gallagher, M. Eads, and M. F. Elmore. 1986. Microbial growth patterns in a parenteral nutrition formulation containing lipid emulsion. J. Parenter. Enteral. Nutr. 10:494-497.
10. Hazen, K. C. 1989. Participation of yeast cell surface hydrophobicity in the adherence of Candida albicans to human epithelial cells. Infect. Immun. 57:1894-1900.
11. Hubsch, A. P., F. S. Powell, P. G. Lereh, and J. E. Duran. 1993. A reconstituted, apolipoprotein A-1 containing lipoprotein reduces tumor necrosis factor release and attenuates shock in endotoxemic rabbits. Circulatory Shock 40:14-23.
12. Ishihashi, S., M. S. Brown, J. L. Goldstein, R. D. Gerard, R. E. Hammer, and J. Herz. 1993. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92:883-893.
13. Jeremias, J., A. Kalo-Klein, and S. S. Witkin. 1991. Individual differences in tumour necrosis factor and interleukin-3 production induced by viable and heat-killed Candida albicans. J. Med. Vet. Mycol. 29:157-163.
14. Jouault, T., G. Lepage, A. Bernigaud, P. A. Trinel, C. Fradin, J. M. Wieruszeski, G. Strecker, and D. Poulain. 1995. β-1.2-linked oligomannosides from Candida albicam act as signals for tumor necrosis factor alpha production. Infect. Immun. 63:2378-2381.
15. Kullberg, B. J., J. W. Van't Wout, and R. Van Furth. 1990. Role of granulocytes in enhanced host resistance to Candida albicans induced by recombinant interleukin-1. Infect. Immun. 58:3319-3324.
16. Lawrence, J., M. Turner, and P. Gilbert. 1988. Microbial contamination in total parenteral nutrition solutions. J. Clin. Pharm. Ther. 13:151-157.
17. Levine, D. M., T. S. Parker, T. M. Donelly, A. Walsh, and A. L. Rubin. 1993. In vivo protection auainst endotoxin by plasma high density lipoprotein. Proc. Natl. Acad. Sci. USA 90:12040-12044.
18. Lynn, W. A., and J. Cohen. 1995. Adjunctive therapy for septic shock: a review of experimental approaches. Clin. Infect. Dis. 20:143-158.
19. Murthy, A. R. K., R. I. Lehrer, S. S. L. Harwig, and K. T. Miyasaki. 1993. In vitro candidastatic properties of the human neutrophil calprotectin complex. J. Immunol. 151:6291-6301.
20. Netea, M. G., W. L. Blok, B. J. Kullberg, M. Bemelmans, M. T. E. Vogels, W. A. Buurman, and J. W. M. Van der Meer. 1995. Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice. J. Infect. Dis. 171:393-399.
21. Netea, M. G., P. N. M. Demacker, B. J. Kullberg, O. C. Boerman, I. Verschueren, A. F. H. Stalenhoef, and J. W. M. Van der Meer. 1996. Low-density-lipoprotein receptor deficient mice are protected from lethal endotoxemia and gram-negative infection. J. Clin. Invest. 97:1366-1372.
22. Odds, F. C. 1988. Pathogenesis of candidosis, p. 252-278. In F. C. Odds (ed.), Candida and candidosis: a review and bibliography, 2nd ed. Bailliere Tindall, London. United Kingdom.
23. Parillu, J. E. 1993. Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 328:1471-1477.
24. Read, T. E., C. Grunfeld, Z. L. Kumwenda, M. C. Calhoun, J. P. Kane, K. R. Feingold, and J. H. Rapp. 1995. Triglyceride-rich lipoproteins prevent septic death in rats. J. Exp. Med. 182:267-272.
25. Rothberg, K. G., Y. S. Ying, B. A. Kamen, and R. G. W. Anderson. 1990. Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate. J. Cell Biol. 111:2931-2938.
26. Steinshamn, S., and A. Waage. 1992. Tumor necrosis factor and interleukin-6 in Candida albicans infection in normal and granulocytopenic mice. Infect. Immun. 60:4003-4008.
27. Tracey, C. J., Y. Fong, D. G. Hesse, K. R. Manogue, A. T. Lee, G. C. Kuo, S. F. Lowry, and A. Cerami. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662-664.
28. Ulevitch, R. J., and A. R. Johnston. 1978. The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum. J. Clin. Invest. 62:1313-1324.
29. Vechiarelli, A., T. Todisco, M. Puliti, M. Dottorini, and F. Bistoni. 1989. Modulation of anti-Candida activity of human alveolar macrophagess by interferon-gamma or interleukin-1-alpha. Am. J. Respir. Cell Mol. Biol. 1:49-55.
30. Wakabayashi, G., J. A. Gelfand, J. F. Burke, R. C. Thomson, and C. A. Dinarello. 1991. A specific receptor antagonist for interleukin-1 prevents Escherichia coli-induced shock in rabbits. FASHB J. 5:338-343.
31. Wey, S. B., M. Mori, M. A. Pfaller, R. F. Woolson, and R. P. Wenzel. 1988. Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch. Intern. Med. 148:2642-2645.
32. Yeaman, M. R., A. S. Ibrahim, J. E. Edwards, A. S. Bayer, and M. A. Ghannoum. 1993. Thrombin-induced rabbit platelet microbicidal protein is fungicidal in vitro. Antimicrob. Agents Chemother. 37:546-553.